Carter Paul Rutherford 4
4 · ALDER BIOPHARMACEUTICALS INC · Filed May 28, 2019
Insider Transaction Report
Form 4
Carter Paul Rutherford
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-23+22,500→ 22,500 totalExercise: $11.01Exp: 2029-05-22→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall fully vest and become exercisable on the date of the 2020 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date.